Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30

$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cryo-Cell International's EV/EBITDA was 43.3× on Nov 11, 2026, against 7.6× a year earlier. Over the last 5 years it ranged from 5.9× to 51.5×, with a median of 10.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	43.3×	+37.0
2025	Dec 31, 2025	6.3×	−3.6
2023	Dec 29, 2023	9.8×	−0.3
2022	Dec 30, 2022	10.2×	−1.7
2021	Dec 31, 2021	11.8×	+4.7
2020	Dec 31, 2020	7.2×	−2.2
2019	Dec 31, 2019	9.3×	−2.3
2018	Dec 31, 2018	11.6×	−3.3
2017	Dec 29, 2017	14.9×	−37.2
2016	Dec 30, 2016	52.2×	+42.0
2015	Dec 31, 2015	10.1×	+0.8
2014	Dec 31, 2014	9.3×	−11.6
2013	Dec 31, 2013	21.0×	−230.7
2012	Mar 30, 2012	251.7×	+210.9
2011	Dec 30, 2011	40.7×	–

Where these numbers come from

Parsed from the XBRL in Cryo-Cell International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing